D-0833-2020 Class I Terminated

Recalled by Taro Pharmaceuticals U.S.A., Inc. — Hawthorne, NY

Recall Details

Product Type
Drugs
Report Date
February 19, 2020
Initiation Date
December 20, 2019
Termination Date
February 23, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.

Reason for Recall

Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.

Distribution Pattern

Nationwide in the U.S. and Puerto Rico.

Code Information

Lot #: 331771, Exp. June 2021